Symbols / EMBC $9.00 -0.99%
EMBC Chart
About
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Instruments & Su | Market Cap | 532.98M |
| Enterprise Value | 1.74B | Income | 139.50M | Sales | 1.08B |
| Book/sh | -10.35 | Cash/sh | 3.40 | Dividend Yield | 6.60% |
| Payout | 25.42% | Employees | 1850 | IPO | — |
| P/E | 3.85 | Forward P/E | 3.12 | PEG | — |
| P/S | 0.49 | P/B | -0.87 | P/C | — |
| EV/EBITDA | 4.75 | EV/Sales | 1.61 | Quick Ratio | 1.54 |
| Current Ratio | 2.64 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | 2.34 | EPS next Y | 2.88 | EPS Growth | — |
| Revenue Growth | -0.30% | Earnings | 2026-05-08 | ROA | 18.36% |
| ROE | — | ROIC | — | Gross Margin | 63.16% |
| Oper. Margin | 29.21% | Profit Margin | 12.92% | Shs Outstand | 59.22M |
| Shs Float | 58.30M | Short Float | 8.12% | Short Ratio | 4.96 |
| Short Interest | — | 52W High | 15.55 | 52W Low | 8.78 |
| Beta | 1.06 | Avg Volume | 775.77K | Volume | 752.36K |
| Target Price | $16.67 | Recom | None | Prev Close | $9.09 |
| Price | $9.00 | Change | -0.99% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$16.67
Mean price target
2. Current target
$9.00
Latest analyst target
3. DCF / Fair value
$57.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.00
Low
$11.00
High
$25.00
Mean
$16.67
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-06 | reit | BTIG | Buy → Buy | $25 |
| 2025-09-05 | reit | BTIG | Buy → Buy | $25 |
| 2025-07-16 | main | Mizuho | Neutral → Neutral | $12 |
| 2025-05-23 | main | Mizuho | Neutral → Neutral | $13 |
| 2025-04-10 | init | Mizuho | — → Neutral | $15 |
| 2024-11-27 | up | BTIG | Neutral → Buy | $26 |
| 2024-07-15 | main | Morgan Stanley | Underweight → Underweight | $12 |
| 2024-05-10 | main | Morgan Stanley | Underweight → Underweight | $13 |
| 2023-11-22 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-10-18 | main | Morgan Stanley | Underweight → Underweight | $15 |
| 2023-08-24 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-07-18 | main | Morgan Stanley | Underweight → Underweight | $19 |
| 2023-05-15 | main | Morgan Stanley | Underweight → Underweight | $29 |
| 2023-01-06 | down | Morgan Stanley | Equal-Weight → Underweight | $28 |
| 2022-12-21 | main | Morgan Stanley | — → Equal-Weight | $31 |
| 2022-10-11 | main | Morgan Stanley | — → Equal-Weight | $33 |
| 2022-09-08 | init | BTIG | — → Neutral | — |
| 2022-08-16 | main | Morgan Stanley | — → Equal-Weight | $36 |
| 2022-08-01 | init | Morgan Stanley | — → Equal-Weight | $33 |
| 2022-06-21 | init | B of A Securities | — → Underperform | $25 |
- Jefferies Financial Group Inc. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat Mon, 09 Mar 2026 10
- Why Embecta Stock Is Down 20% This Week - TIKR.com hu, 27 Nov 2025 08
- We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance hu, 12 Feb 2026 08
- Precision Trading with Embecta Corp. (EMBC) Risk Zones - Stock Traders Daily Mon, 02 Mar 2026 17
- embecta (Nasdaq: EMBC) to name CEO Dev Kurdikar Board Chair as Melcher retires - Stock Titan Mon, 17 Nov 2025 08
- Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade) - Seeking Alpha Sat, 29 Nov 2025 08
- Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business hu, 05 Feb 2026 08
- Embecta Corp. (EMBC) Stock Analysis: Unlocking 37% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews Fri, 23 Jan 2026 08
- EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? - Nasdaq hu, 20 Nov 2025 08
- Embecta (NASDAQ:EMBC) Sets New 52-Week Low - Here's What Happened - MarketBeat Fri, 06 Mar 2026 16
- Embecta Corp. to Host Conference Call for Fiscal Q1 2026 Financial Results and Operational Update - Quiver Quantitative hu, 22 Jan 2026 08
- Is Embecta Corp. (NASDAQ:EMBC) Potentially Undervalued? - Yahoo Finance Fri, 31 Oct 2025 07
- embecta CEO Dev Kurdikar adds chair role as Pomeroy becomes lead director - Stock Titan Wed, 11 Feb 2026 08
- Embecta stock gets a boost on Q3 beats, raised guidance - Drug Delivery Business Fri, 08 Aug 2025 07
- Technical Reactions to EMBC Trends in Macro Strategies - Stock Traders Daily hu, 19 Feb 2026 15
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | MORRIS MILTON MAYO | Director | — | 2026-02-11 00:00:00 | D |
| 1 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | HOMBACH ROBERT J. CPA | Director | — | 2026-02-11 00:00:00 | D |
| 2 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | PRANGE KAREN N. | Director | — | 2026-02-11 00:00:00 | D |
| 3 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | POMEROY CLAIRE | Director | — | 2026-02-11 00:00:00 | D |
| 4 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | ANDERSON CARRIE L | Director | — | 2026-02-11 00:00:00 | D |
| 5 | 22841 | — | — | Stock Award(Grant) at price 0.00 per share. | REIDY CHRISTOPHER R | Director | — | 2026-02-11 00:00:00 | D |
| 6 | 38783 | — | — | Stock Award(Grant) at price 0.00 per share. | CASNER JEAN | Officer | — | 2025-11-26 00:00:00 | D |
| 7 | 104050 | — | — | Stock Award(Grant) at price 0.00 per share. | MANN JEFFREY Z | General Counsel | — | 2025-11-26 00:00:00 | D |
| 8 | 125613 | — | — | Stock Award(Grant) at price 0.00 per share. | ELGUICZE JACOB | Chief Financial Officer | — | 2025-11-26 00:00:00 | D |
| 9 | 392012 | — | — | Stock Award(Grant) at price 0.00 per share. | KURDIKAR DEVDATT | Chief Executive Officer | — | 2025-11-26 00:00:00 | D |
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -16.29M | -24.82M | -835.00K | -7.60M |
| TaxRateForCalcs | 0.30 | 0.21 | 0.33 | 0.13 |
| NormalizedEBITDA | 338.60M | 310.90M | 247.80M | 393.40M |
| TotalUnusualItems | -54.30M | -118.20M | -2.50M | -58.90M |
| TotalUnusualItemsExcludingGoodwill | -54.30M | -118.20M | -2.50M | -58.90M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 95.40M | 78.30M | 70.40M | 223.60M |
| ReconciledDepreciation | 40.70M | 36.20M | 32.60M | 31.70M |
| ReconciledCostOfRevenue | 373.30M | 358.00M | 370.90M | 354.60M |
| EBITDA | 284.30M | 192.70M | 245.30M | 334.50M |
| EBIT | 243.60M | 156.50M | 212.70M | 302.80M |
| NetInterestIncome | -107.30M | -112.30M | -107.00M | -46.20M |
| InterestExpense | 107.30M | 112.30M | 107.00M | 46.20M |
| NormalizedIncome | 133.41M | 171.68M | 72.06M | 274.90M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 95.40M | 78.30M | 70.40M | 223.60M |
| TotalExpenses | 784.00M | 838.10M | 896.80M | 761.00M |
| TotalOperatingIncomeAsReported | 242.10M | 166.80M | 221.50M | 309.60M |
| DilutedAverageShares | 58.91M | 58.33M | 57.70M | 57.48M |
| BasicAverageShares | 58.17M | 57.57M | 57.24M | 57.04M |
| DilutedEPS | 1.62 | 1.34 | 1.22 | 3.89 |
| BasicEPS | 1.64 | 1.36 | 1.23 | 3.92 |
| DilutedNIAvailtoComStockholders | 95.40M | 78.30M | 70.40M | 223.60M |
| NetIncomeCommonStockholders | 95.40M | 78.30M | 70.40M | 223.60M |
| NetIncome | 95.40M | 78.30M | 70.40M | 223.60M |
| NetIncomeIncludingNoncontrollingInterests | 95.40M | 78.30M | 70.40M | 223.60M |
| NetIncomeContinuousOperations | 95.40M | 78.30M | 70.40M | 223.60M |
| TaxProvision | 40.90M | -34.10M | 35.30M | 33.00M |
| PretaxIncome | 136.30M | 44.20M | 105.70M | 256.60M |
| OtherIncomeExpense | -52.80M | -128.50M | -11.30M | -65.70M |
| OtherNonOperatingIncomeExpenses | 1.50M | -10.30M | -8.80M | -6.80M |
| SpecialIncomeCharges | -54.30M | -118.20M | -2.50M | -58.90M |
| OtherSpecialCharges | 15.70M | |||
| ImpairmentOfCapitalAssets | 0.00 | 0.00 | 2.50M | 58.90M |
| RestructuringAndMergernAcquisition | 38.60M | 118.20M | 98.30M | |
| NetNonOperatingInterestIncomeExpense | -107.30M | -112.30M | -107.00M | -46.20M |
| InterestExpenseNonOperating | 107.30M | 112.30M | 107.00M | 46.20M |
| OperatingIncome | 296.40M | 285.00M | 224.00M | 368.50M |
| OperatingExpense | 380.40M | 450.20M | 525.90M | 406.40M |
| OtherOperatingExpenses | 700.00K | 99.40M | 44.70M | 4.80M |
| DepreciationAmortizationDepletionIncomeStatement | 10.40M | 6.30M | 0.00 | |
| DepreciationAndAmortizationInIncomeStatement | 10.40M | 6.30M | 0.00 | |
| Amortization | 10.40M | 6.30M | 0.00 | |
| AmortizationOfIntangiblesIncomeStatement | 10.40M | 6.30M | 0.00 | |
| ResearchAndDevelopment | 37.30M | 78.80M | 85.20M | 66.90M |
| SellingGeneralAndAdministration | 332.00M | 365.10M | 341.30M | 294.80M |
| SellingAndMarketingExpense | 240.00M | |||
| GrossProfit | 676.80M | 735.20M | 749.90M | 774.90M |
| CostOfRevenue | 403.60M | 387.90M | 370.90M | 354.60M |
| TotalRevenue | 1.08B | 1.12B | 1.12B | 1.13B |
| OperatingRevenue | 1.08B | 1.12B | 1.12B | 1.13B |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 58.50M | 57.71M | 57.33M | 57.06M |
| ShareIssued | 58.50M | 57.71M | 57.33M | 57.06M |
| NetDebt | 1.17B | 1.31B | 1.28B | 1.28B |
| TotalDebt | 1.43B | 1.61B | 1.64B | 1.64B |
| TangibleBookValue | -673.60M | -762.60M | -846.40M | -916.00M |
| InvestedCapital | 747.00M | 835.90M | 781.70M | 716.20M |
| WorkingCapital | 369.90M | 387.00M | 395.60M | 363.70M |
| NetTangibleAssets | -673.60M | -762.60M | -846.40M | -916.00M |
| CapitalLeaseObligations | 32.10M | 33.60M | 35.10M | 36.20M |
| CommonStockEquity | -651.20M | -738.90M | -821.70M | -891.40M |
| TotalCapitalization | 737.50M | 826.40M | 772.20M | 706.70M |
| TotalEquityGrossMinorityInterest | -651.20M | -738.90M | -821.70M | -891.40M |
| StockholdersEquity | -651.20M | -738.90M | -821.70M | -891.40M |
| OtherEquityInterest | 864.80M | |||
| GainsLossesNotAffectingRetainedEarnings | -285.60M | -292.80M | -309.10M | -324.90M |
| OtherEquityAdjustments | -285.60M | -292.80M | -309.10M | -324.90M |
| RetainedEarnings | -445.60M | -498.60M | -541.10M | -577.10M |
| AdditionalPaidInCapital | 80.00M | 52.50M | 27.90M | 10.00M |
| CapitalStock | 0.00 | 0.00 | 600.00K | 600.00K |
| CommonStock | 0.00 | 0.00 | 600.00K | 600.00K |
| TotalLiabilitiesNetMinorityInterest | 1.74B | 2.02B | 2.04B | 1.98B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.48B | 1.65B | 1.68B | 1.68B |
| OtherNonCurrentLiabilities | 63.20M | 54.70M | 57.20M | 46.10M |
| NonCurrentDeferredLiabilities | 46.10M | 29.70M | ||
| NonCurrentDeferredTaxesLiabilities | 46.10M | 29.70M | ||
| LongTermDebtAndCapitalLeaseObligation | 1.42B | 1.60B | 1.63B | 1.63B |
| LongTermCapitalLeaseObligation | 28.70M | 30.20M | 31.50M | 32.60M |
| LongTermDebt | 1.39B | 1.57B | 1.59B | 1.60B |
| CurrentLiabilities | 261.50M | 374.00M | 353.50M | 301.00M |
| CurrentDebtAndCapitalLeaseObligation | 12.90M | 12.90M | 13.10M | 13.10M |
| CurrentCapitalLeaseObligation | 3.40M | 3.40M | 3.60M | 3.60M |
| CurrentDebt | 9.50M | 9.50M | 9.50M | 9.50M |
| OtherCurrentBorrowings | 9.50M | 9.50M | 9.50M | 9.50M |
| PayablesAndAccruedExpenses | 248.60M | 361.10M | 340.40M | 287.90M |
| CurrentAccruedExpenses | 148.30M | 200.90M | 180.20M | 152.80M |
| Payables | 100.30M | 160.20M | 160.20M | 135.10M |
| DuetoRelatedPartiesCurrent | 16.30M | 42.50M | 73.10M | 66.50M |
| TotalTaxPayable | 9.80M | 26.70M | 33.60M | 27.20M |
| IncomeTaxPayable | 9.80M | 26.70M | 33.60M | 27.20M |
| AccountsPayable | 74.20M | 91.00M | 53.50M | 41.40M |
| TotalAssets | 1.09B | 1.29B | 1.21B | 1.09B |
| TotalNonCurrentAssets | 459.50M | 524.30M | 465.30M | 421.70M |
| OtherNonCurrentAssets | 179.90M | 210.20M | 140.40M | 95.50M |
| NonCurrentDeferredAssets | 95.50M | 11.40M | ||
| NonCurrentDeferredTaxesAssets | 95.50M | 11.40M | ||
| GoodwillAndOtherIntangibleAssets | 22.40M | 23.70M | 24.70M | 24.60M |
| OtherIntangibleAssets | 7.00M | 8.10M | 9.10M | 8.90M |
| Goodwill | 15.40M | 15.60M | 15.60M | 15.70M |
| NetPPE | 257.20M | 290.40M | 300.20M | 301.60M |
| AccumulatedDepreciation | -534.10M | -488.70M | -447.70M | -400.00M |
| GrossPPE | 791.30M | 779.10M | 747.90M | 701.60M |
| Leases | 13.20M | 11.90M | 9.10M | 6.50M |
| ConstructionInProgress | 58.60M | 35.10M | 44.80M | 64.90M |
| MachineryFurnitureEquipment | 595.40M | 607.30M | 567.20M | 505.10M |
| BuildingsAndImprovements | 121.00M | 121.70M | 124.50M | 123.70M |
| LandAndImprovements | 3.10M | 3.10M | 2.30M | 1.40M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 631.40M | 761.00M | 749.10M | 664.70M |
| OtherCurrentAssets | 75.30M | 68.50M | 111.40M | 77.90M |
| RestrictedCash | 3.10M | 6.70M | 200.00K | |
| PrepaidAssets | 77.90M | 23.20M | ||
| Inventory | 178.60M | 171.50M | 152.10M | 122.80M |
| FinishedGoods | 116.90M | 126.30M | 111.90M | 93.80M |
| WorkInProcess | 11.70M | 4.80M | 8.10M | 5.60M |
| RawMaterials | 50.00M | 40.40M | 32.10M | 23.40M |
| Receivables | 148.90M | 246.80M | 159.10M | 133.10M |
| DuefromRelatedPartiesCurrent | 3.30M | 53.80M | 142.40M | 110.90M |
| AccountsReceivable | 145.60M | 193.00M | 16.70M | 22.20M |
| AllowanceForDoubtfulAccountsReceivable | -1.80M | -2.80M | -1.00M | -1.30M |
| GrossAccountsReceivable | 147.40M | 195.80M | 17.70M | 23.50M |
| CashCashEquivalentsAndShortTermInvestments | 225.50M | 267.50M | 326.30M | 330.90M |
| CashAndCashEquivalents | 225.50M | 267.50M | 326.30M | 330.90M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | 182.40M | 19.90M | 41.20M | 388.20M |
| RepaymentOfDebt | -186.00M | -35.90M | -10.70M | -12.20M |
| IssuanceOfDebt | 0.00 | 0.00 | 1.45B | 0.00 |
| CapitalExpenditure | -9.30M | -15.80M | -26.50M | -24.00M |
| InterestPaidSupplementalData | 103.80M | 117.70M | 111.00M | 38.90M |
| IncomeTaxPaidSupplementalData | 50.10M | 29.10M | 30.40M | 15.60M |
| EndCashPosition | 228.60M | 274.20M | 326.50M | 330.90M |
| BeginningCashPosition | 274.20M | 326.50M | 330.90M | 0.00 |
| EffectOfExchangeRateChanges | -1.30M | 1.20M | 3.10M | -9.30M |
| ChangesInCash | -44.30M | -53.50M | -7.50M | 340.20M |
| FinancingCashFlow | -226.70M | -73.40M | -48.70M | -48.00M |
| CashFlowFromContinuingFinancingActivities | -226.70M | -73.40M | -48.70M | -48.00M |
| NetOtherFinancingCharges | -5.70M | -3.00M | -3.60M | -1.48B |
| CashDividendsPaid | -35.00M | -34.50M | -34.40M | -8.60M |
| CommonStockDividendPaid | -35.00M | -34.50M | -34.40M | -8.60M |
| NetIssuancePaymentsOfDebt | -186.00M | -35.90M | -10.70M | 1.44B |
| NetShortTermDebtIssuance | 0.00 | 0.00 | -5.60M | 0.00 |
| ShortTermDebtPayments | 0.00 | 0.00 | -5.60M | 0.00 |
| NetLongTermDebtIssuance | -186.00M | -35.90M | -10.70M | 1.44B |
| LongTermDebtPayments | -186.00M | -35.90M | -10.70M | -6.60M |
| LongTermDebtIssuance | 0.00 | 0.00 | 1.45B | 0.00 |
| InvestingCashFlow | -9.30M | -15.80M | -26.50M | -24.00M |
| CashFlowFromContinuingInvestingActivities | -9.30M | -15.80M | -26.50M | -24.00M |
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | -400.00K | -2.40M |
| PurchaseOfIntangibles | 0.00 | 0.00 | -400.00K | -2.40M |
| CapitalExpenditureReported | -9.30M | -15.80M | -26.50M | -23.60M |
| OperatingCashFlow | 191.70M | 35.70M | 67.70M | 412.20M |
| CashFlowFromContinuingOperatingActivities | 191.70M | 35.70M | 67.70M | 412.20M |
| ChangeInWorkingCapital | -23.70M | -47.70M | -80.00M | 102.60M |
| ChangeInOtherWorkingCapital | 26.70M | 30.80M | -39.30M | -39.90M |
| ChangeInOtherCurrentAssets | 500.00K | 500.00K | ||
| ChangeInPayablesAndAccruedExpense | -97.00M | 73.20M | -4.70M | 87.20M |
| ChangeInPayable | -97.00M | 73.20M | -4.70M | 87.20M |
| ChangeInAccountPayable | -68.90M | 60.00M | 7.90M | 76.90M |
| ChangeInTaxPayable | -28.10M | 13.20M | -12.60M | 10.30M |
| ChangeInIncomeTaxPayable | -28.10M | 13.20M | -12.60M | 10.30M |
| ChangeInPrepaidAssets | 8.50M | 39.50M | -14.20M | -44.00M |
| ChangeInInventory | -6.10M | -16.50M | -28.80M | -23.40M |
| ChangeInReceivables | 44.20M | -174.70M | 7.00M | 122.70M |
| ChangesInAccountReceivables | 44.20M | -174.70M | 7.00M | 122.70M |
| OtherNonCashItems | 19.50M | 13.20M | 6.40M | 3.20M |
| StockBasedCompensation | 31.60M | 26.30M | 21.50M | 18.70M |
| AssetImpairmentCharge | 10.60M | 0.00 | 2.50M | 58.90M |
| DeferredTax | 17.60M | -70.60M | 14.30M | -26.50M |
| DeferredIncomeTax | 17.60M | -70.60M | 14.30M | -26.50M |
| DepreciationAmortizationDepletion | 40.70M | 36.20M | 32.60M | 31.70M |
| DepreciationAndAmortization | 40.70M | 36.20M | 32.60M | 31.70M |
| OperatingGainsLosses | 10.20M | 9.00M | ||
| PensionAndEmployeeBenefitExpense | 10.20M | 9.00M | ||
| NetIncomeFromContinuingOperations | 95.40M | 78.30M | 70.40M | 223.60M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for EMBC
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|